Guangdong Transtek Medical Electronics Co.Ltd(300562) internal control assurance report xksbz [2022] No. zl10048
Guangdong Transtek Medical Electronics Co.Ltd(300562)
Internal control assurance report
Table of contents page 1. Internal control assurance report 1-2. Enterprise internal control self-evaluation report 1-10
Internal control assurance report
Xin Hui Shi Bao Zi [2022] No. zl10048 Guangdong Transtek Medical Electronics Co.Ltd(300562) all shareholders:
We have accepted the entrustment to carry out the verification of the board of directors of Guangdong Transtek Medical Electronics Co.Ltd(300562) (hereinafter referred to as ” Guangdong Transtek Medical Electronics Co.Ltd(300562) “) on the effectiveness of internal control over Guangdong Transtek Medical Electronics Co.Ltd(300562) financial reporting on December 31, 2021.
1、 Responsibilities of the board of directors for internal control
Guangdong Transtek Medical Electronics Co.Ltd(300562) the responsibility of the board of directors is to establish, improve and effectively implement internal control in accordance with the relevant provisions of the basic norms of enterprise internal control, evaluate its effectiveness, and truthfully disclose the internal control evaluation report..
2、 Responsibilities of Certified Public Accountants
Our responsibility is to issue assurance conclusions on the effectiveness of internal control over financial reporting based on the implementation of assurance work..
3、 Job overview
We have carried out the assurance business in accordance with the provisions of other assurance business standards for Chinese certified public accountants No. 3101 – assurance business other than audit or review of historical financial information. The standards require us to comply with the code of professional ethics of Chinese certified public accountants, plan and implement the assurance work, so as to obtain reasonable assurance on whether Lexin maintains effective internal control over financial reporting in all material aspects in accordance with the relevant provisions of the basic norms of enterprise internal control on December 31, 2021. In the process of performing the assurance work, we have implemented other procedures including understanding, testing and evaluating the effectiveness of internal control and other procedures that we deem necessary. We believe that our assurance work provides a reasonable basis for issuing assurance conclusions.
4、 Description of significant inherent limitations
Internal control has inherent limitations, and there is the possibility of undetected misstatement due to error or fraud. In addition, due to changes in circumstances that may lead to inappropriate internal control or reduce the degree of compliance with control policies and procedures, there is a certain risk to speculate the effectiveness of internal control in the future according to the internal control evaluation results
5、 Assurance conclusion
We believe that Guangdong Transtek Medical Electronics Co.Ltd(300562) has maintained effective internal control over financial reporting in all major aspects in accordance with the relevant provisions of the basic norms of internal control of enterprises on December 31, 2021. Lixin Certified Public Accountants (special general partnership) Chinese certified public accountant: Liang Qianhai
Shanghai China
Chinese certified public accountant: Ma Yue
March 17, 2002
Guangdong Transtek Medical Electronics Co.Ltd(300562)
Related to financial statements in 2021
Self assessment report on internal control
Guangdong Transtek Medical Electronics Co.Ltd(300562) all shareholders:
According to the provisions of the basic norms of enterprise internal control and its supporting guidelines and other internal control supervision requirements (hereinafter referred to as the enterprise internal control standard system), combined with the internal control system and evaluation methods of the company (hereinafter referred to as the “company”), on the basis of daily and special supervision of internal control, We evaluated the effectiveness of the company’s internal control on December 31, 2021 (the benchmark date of the internal control evaluation report).
1、 Important statement
It is the responsibility of the board of directors of the company to establish, improve and effectively implement internal control, evaluate its effectiveness and truthfully disclose the internal control evaluation report in accordance with the provisions of the enterprise’s internal control standard system. The board of supervisors shall supervise the establishment and implementation of internal control by the board of directors. The management is responsible for organizing and leading the daily operation of the enterprise’s internal control. The board of directors, the board of supervisors and the directors, supervisors and senior managers of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this report, and bear individual and joint legal liabilities for the authenticity, accuracy and completeness of the contents of the report.
The objective of the company’s internal control is to reasonably ensure the legal compliance of operation and management, asset safety, authenticity and integrity of financial reports and relevant information, improve operation efficiency and effect, and promote the realization of development strategy. Due to the inherent limitations of internal control, it can only provide reasonable assurance for the realization of the above objectives. In addition, as changes in circumstances may lead to inappropriate internal control or reduced compliance with control policies and procedures, there is a certain risk to speculate the effectiveness of internal control in the future according to the internal control evaluation results.
2、 Internal control evaluation conclusion
According to the identification of major defects in the company’s internal control over financial reporting, there are no major defects in the internal control over financial reporting on the benchmark date of the internal control evaluation report. The board of Directors believes that the company has maintained effective internal control over financial reporting in all major aspects in accordance with the requirements of the enterprise’s internal control standard system and relevant regulations.
According to the identification of major defects in the company’s internal control over non-financial reports, the company found no major defects in the company’s internal control over non-financial reports on the benchmark date of the internal control evaluation report.
There are no factors affecting the evaluation conclusion of the effectiveness of internal control from the base date of the internal control evaluation report to the date of issuance of the internal control evaluation report.
3、 Internal control evaluation
(I) evaluation scope of internal control
According to the risk oriented principle, the company determines the main units, businesses and matters included in the evaluation scope and high-risk areas. The main units included in the evaluation scope include all departments of the company, Zhongshan Chuangyuan sensor Co., Ltd., a wholly-owned subsidiary of China, Shenzhen Guangdong Transtek Medical Electronics Co.Ltd(300562) Electronics Co., Ltd., Zhongshan Chuangyuan Trading Co., Ltd., Zhongshan Lexin Electronics Co., Ltd., Zhongshan Leheng Electronics Co., Ltd., Mio labs Inc. and Lifesense US holdings LLC., a wholly-owned subsidiary of Hong Kong Chuangyuan Co., Ltd And the holding subsidiaries Shenzhen Ruikang Hongye Technology Development Co., Ltd., Guangzhou Lexin Yuhong medical industry investment fund partnership (limited partnership), sound source technology (Shenzhen) Co., Ltd., zaoniao Technology (Shenzhen) Co., Ltd., winte Technology Co., Ltd. Guangdong Transtek Medical Electronics Co.Ltd(300562) remote technology (Zhuhai) Co., Ltd. the main businesses and matters included in the evaluation scope include: internal environment, risk assessment Control measures, information and communication, inspection and supervision.
1. Internal environment
(1) Corporate governance and organizational structure
① Corporate governance structure
In accordance with the provisions of the company law, the securities law and other relevant laws and regulations, the company has successively formulated and adopted the articles of association, the rules of procedure of the general meeting of shareholders, the rules of procedure of the board of directors, the rules of procedure of the board of supervisors, the decision-making system of connected transactions, the management system of heavy investment, the management system of external guarantee, the management system of raised funds, the working system of independent directors A series of rules and regulations such as information disclosure management system, insider registration management system and external information user management system have defined the responsibilities and authorities of various institutions in decision-making, implementation and supervision, and formed a scientific and effective division of responsibilities and check and balance mechanism. The general meeting of shareholders, the board of directors, the board of supervisors and all special committees under the board of directors shall perform their duties, exercise their rights, vote or express corresponding opinions in accordance with relevant working procedures.
② Organizational structure
In accordance with the company law, the articles of association and other relevant laws and regulations, the company has established a corporate governance structure composed of the general meeting of shareholders, the board of directors, the board of supervisors and the management, and established an independent director system; The board of directors of the company has a strategy committee, an audit committee, a remuneration and assessment committee, a nomination committee and other special committees; For the smooth progress of the company’s daily production, operation and management, the company’s management has set up senior managers such as general manager, deputy general manager, chief financial officer and Secretary of the board of directors, and established RPM Bu, remote cloud technology Bu, heart health Bu, happy time, intelligent sphygmomanometer Bu, intelligent weighing Bu, intelligent wearing Bu, intelligent headset Bu, R & D department, intelligent manufacturing department, quality management department Supply chain department and functional departments. The functional departments include operation & Human Resources Department, administration & EHS department, information management department, finance department, audit department and legal department. According to the strategic planning of the company, the functional departments and subsidiaries of the company have formulated medium and long-term plans and annual plans, and formulated the post responsibilities of each department. Each functional department has a clear division of labor and
Take their responsibilities, cooperate with each other, contain each other and supervise each other. As of December 31, 2021, the company has five wholly-owned subsidiaries in China, namely Zhongshan Chuangyuan sensor Co., Ltd., Shenzhen Guangdong Transtek Medical Electronics Co.Ltd(300562) Electronics Co., Ltd., Zhongshan Chuangyuan Trading Co., Ltd., Zhongshan Lexin Electronics Co., Ltd. and Zhongshan Leheng Electronics Co., Ltd; Three overseas wholly-owned subsidiaries, namely Mio labs Inc., Hong Kong Chuangyuan Co., Ltd. and Lifesense US holdings LLC; One overseas holding subsidiary is Wintech Technology Co., Ltd., and five holding subsidiaries are Shenzhen Ruikang Hongye Technology Development Co., Ltd., Guangzhou Lexin Yuhong medical industry investment fund partnership (limited partnership), sound source technology (Shenzhen) Co., Ltd., early bird Technology (Shenzhen) Co., Ltd., Guangdong Transtek Medical Electronics Co.Ltd(300562) remote technology (Zhuhai) Co., Ltd. The company conducts necessary supervision and management on the operation, capital, personnel, finance and other major aspects of its holding subsidiaries by appointing executive directors, supervisors and senior managers in accordance with laws, regulations and the articles of association.
(2) Establishment of internal audit institutions
The company has set up an audit department, formulated management systems related to internal audit, and equipped with full-time auditors. The audit department is responsible for and reports to the audit committee of the board of directors. In accordance with the requirements of national laws, regulations and relevant systems, independently and objectively exercise the functions and powers of internal audit, inspect and supervise the internal control of the company and its holding subsidiaries, conduct internal audit on financial and business activities, and put forward audit suggestions.
(3) Corporate culture
The company’s corporate culture is customer-oriented, innovative and professional to meet customer needs, takes becoming a world-class health IOT and digital health service provider as the strategic goal, and takes customer-oriented, innovative, responsible and pursuing excellence as the values. The company regularly evaluates the implementation of corporate culture construction and provides organizational guarantee and financial support for various corporate culture activities. Cadres of all departments assume the role of cultural disseminator and inheritor, and play their due role as a benchmark in work and project delivery. The company publicizes the concept of corporate culture and establishes a good cultural image of the enterprise through design display, employee training, internal and external media communication, sports and cultural activities and other forms. At present, the company has formed a corporate culture environment of active innovation and pursuit of excellence, and a relatively perfect corporate culture system from concept to behavior. The company’s corporate culture has been highly recognized by employees and plays a role in promoting the development of the company and guiding employees’ behavior.
(4) Human resource management
The company adheres to the talent concept of “taking people as posts” and “operators as achievements”, and establishes a series of management systems such as personnel management regulations, salary management regulations, attendance management regulations, training management system and welfare management system. The company has established a talent evaluation mechanism based on strategy, realized incentive mechanisms such as salary performance management, internal professional title promotion and technical value sharing, and established a smooth employee communication channel. According to the growth of business performance, the company gradually improves the treatment of employees, continuously improves the working environment of employees, and pays attention to the health and safety of employees. The company strictly implements the national
Relevant regulations on social insurance, housing provident fund and other relevant provisions shall pay “five insurances and one fund” for the company’s employees in time and in full.
2. Objective management and risk control
(1) Target management
The company’s business activities comply with national laws, regulations, rules and other relevant regulations;
Establish and improve the internal organizational structure that meets the requirements of modern enterprise management, form a scientific decision-making mechanism, implementation mechanism and supervision mechanism, improve the efficiency and efficiency of the company’s operation, and ensure the realization of the company’s operation and management objectives;
Establish a good internal business environment, prevent and timely detect and correct all kinds of errors and fraud, and protect the safety and integrity of the company’s property;
Establish and improve an effective risk control system, strengthen risk management and ensure the healthy operation of the company’s business activities;
Ensure that the information disclosed by the company is true, accurate and complete.
(2) Risk identification, assessment and response
The company is committed to family health management, supplemented by specific strategies and business process plans to clearly convey the company’s business objectives to every employee
